U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694921) titled 'Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease' on July 05.
Brief Summary: Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized primarily by cognitive impairment as its main clinical symptom, often accompanied by emotional disturbances such as depression and anxiety, imposing a significant disease burden. Temporal Interference Stimulation (TIS) is an emerging non-invasive electrical stimulation technique that precisely targets deep structures within the hippocampus through interference of multiple electric fields. This study will administer a two-week TIS treatment to...